NCT05895110 To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2 Status COMPLETED Phase NA
NCT05894655 Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences Status COMPLETED Phase NA
NCT05893420 A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning Status ACTIVE_NOT_RECRUITING Phase NA
NCT05892549 COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics Status RECRUITING Phase N/A
NCT05890612 A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19 Status RECRUITING Phase N/A
NCT05890560 Two-year Efficacy of Three Exercise Rehabilitation Strategies on Dyspnea in Patients Who Presented With Secondary Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia Status UNKNOWN Phase N/A
NCT05886829 Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III Status COMPLETED Phase PHASE2/PHASE3
NCT05886816 Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 Status RECRUITING Phase PHASE2
NCT05886790 A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes Status UNKNOWN Phase NA
NCT05884554 A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883. Status COMPLETED Phase PHASE1
NCT05882331 Extracorporeal Photopheresis as a Possible Therapeutic Approach to Adults With Severe and Critical COVID-19 Status COMPLETED Phase NA
NCT05881135 Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05877534 Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study Status ENROLLING_BY_INVITATION Phase NA
NCT05876377 Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05876364 Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19) Status UNKNOWN Phase PHASE1
NCT05875701 Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines Status COMPLETED Phase PHASE3